Impaired cognition in narcolepsy: clinical and neurobiological perspectives

被引:0
|
作者
Cano, Christopher A. [1 ,2 ]
Harel, Brian T. [3 ]
Scammell, Thomas E. [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Neurol, 330 Brookline Ave, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Neurol, Boston, MA USA
[3] Takeda Dev Ctr Amer Inc, Neurosci Therapeut Area Unit, Cambridge, MA USA
关键词
narcolepsy; orexin; hypocretin; cognition; attention; executive function; memory; arousal; CORTICAL ACETYLCHOLINE-RELEASE; PREFRONTAL CORTEX; HYPOCRETIN-OREXIN; SUSTAINED ATTENTION; EXECUTIVE FUNCTIONS; MEMORY IMPAIRMENT; SODIUM OXYBATE; DOPAMINE; PERFORMANCE; TASK;
D O I
10.1093/sleep/zsae150
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In addition to well-known symptoms such as sleepiness and cataplexy, many people with narcolepsy have impaired cognition, reporting inattention, poor memory, and other concerns. Unfortunately, research on cognition in narcolepsy has been limited. Strong evidence demonstrates difficulties with sustained attention, but evidence for executive dysfunction and impaired memory is mixed. Animal research provides some insights into how loss of the orexin neurons in narcolepsy type 1 may give rise to impaired cognition via dysfunction of the prefrontal cortex, and cholinergic and monoaminergic systems. This paper reviews some of these clinical and preclinical findings, provides a neurobiological framework to understand these deficits, and highlights some of the many key unanswered questions.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Clinical autonomic dysfunction in narcolepsy type 1
    Barateau, Lucie
    Chenini, Sofiene
    Evangelista, Elisa
    Jaussent, Isabelle
    Lopez, Regis
    Dauvilliers, Yves
    SLEEP, 2019, 42 (12)
  • [42] The Neurobiological Basis of Cognition: Identification by Multi-Input, Multioutput Nonlinear Dynamic Modeling
    Berger, Theodore W.
    Song, Dong
    Chan, Rosa H. M.
    Marmarelis, Vasilis Z.
    PROCEEDINGS OF THE IEEE, 2010, 98 (03) : 356 - 374
  • [43] Clinical Features of Narcolepsy
    Heidbreder, A.
    Mueller, T.
    Young, P.
    KLINISCHE NEUROPHYSIOLOGIE, 2008, 39 (04) : 249 - 255
  • [44] A rating measure of ADHD-related neuropsychological impairment in children and adolescents: Data from the Cognition and Motivation in Everyday Life (CAMEL) Scale from population and clinical samples
    Van Liefferinge, Dagmar
    Sonuga-Barke, Edmund
    Van Broeck, Nady
    Van Der Oord, Saskia
    Lemiere, Jurgen
    Danckaerts, Marina
    CHILD NEUROPSYCHOLOGY, 2017, 23 (04) : 483 - 501
  • [45] IMPAIRED EFFORTFUL COGNITION IN DEPRESSION
    TANCER, ME
    BROWN, TM
    EVANS, DL
    EKSTROM, D
    HAGGERTY, JJ
    PEDERSEN, C
    GOLDEN, RN
    PSYCHIATRY RESEARCH, 1990, 31 (02) : 161 - 168
  • [46] Effects of nicotine withdrawal on cognition in a clinical trial setting
    Wesnes, Keith A.
    Edgar, Chris J.
    Kezic, Iva
    Salih, Hiba Mahde
    de Boer, Peter
    PSYCHOPHARMACOLOGY, 2013, 229 (01) : 133 - 140
  • [47] The impact of anxiety upon cognition: perspectives from human threat of shock studies
    Robinson, Oliver J.
    Vytal, Katherine
    Cornwell, Brian R.
    Grillon, Christian
    FRONTIERS IN HUMAN NEUROSCIENCE, 2013, 7
  • [48] The Effects of Aging and Cognition on Impaired Clinical Insight in Schizophrenia Across the Adult Lifespan
    Gerretsen, Philip
    Voineskos, Aristotle N.
    Menon, Mahesh
    Graff-Guerrero, Ariel
    Pollock, Bruce G.
    Mamo, David C.
    Rajji, Tarek K.
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09)
  • [49] Impaired facilitation of self-control cognition by glucose in patients with schizophrenia: A randomized controlled study
    Leung, Chung-Ming
    Stone, William S.
    Lee, Edwin Ho-Ming
    Seidman, Larry J.
    Chen, Eric Yu-Hai
    SCHIZOPHRENIA RESEARCH, 2014, 156 (01) : 38 - 45
  • [50] Cognitive neuropharmacology:: New perspectives for the pharmacology of cognition
    Le Merrer, J
    Noguès, X
    PHARMACOLOGICAL RESEARCH, 2000, 41 (05) : 503 - 514